Pin Lu

Clonal evolution underlying leukemia progression and Richter transformation in patients with ibrutinib-relapsed CLL

Sabah Kadri, Jimmy Lee, Carrie Fitzpatrick et al. · Blood Advances · 2017 · 132 citations · Full text

Medicine, Genetics, Oncology +17

SYK inhibition and response prediction in diffuse large B-cell lymphoma

Shuhua Cheng, Greg Coffey, Xu Hannah Zhang et al. · Blood · 2011 · 106 citations

Medicine, Cancer Biology, Oncology +14

Characterization of ibrutinib‐sensitive and ‐resistant mantle lymphoma cells

Jiao Ma, Pin Lu, Ailin Guo et al. · British Journal of Haematology · 2014 · 89 citations

Medicine, Oncology, Pharmacology +17

Identification of a structurally novel BTK mutation that drives ibrutinib resistance in CLL

Shruti Sharma, Natalie Galanina, Ailin Guo et al. · Oncotarget · 2016 · 89 citations · Full text

Medicine, Molecular Biology, Oncology +16

BTK Inhibition Targets in Vivo CLL Proliferation Through Its Effects On B-Cell Receptor Signaling Activity.

Y. Lynn Wang, Shuhua Cheng, Jiao Ma et al. · Blood · 2012 · 78 citations

Life Sciences, Hematology, Oncology +14